Corticosteroids in hypovolemic shock

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 20, Issue 5, 1998, Pages 571-588

  Waddell, Lori S ^a   Drobatz, Kenneth J ^a,b,c   Otto, Cynthia M ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b AMER COLL OF VET INT MEDICINE   (United States)

^c Amer Coll Vet Emergency C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 3042959460     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Ganong WF: Cardiovascular homeostasis in health and disease, in Review of Medical Physiology, ed 17. Norwich, CT, Appleton & Lange, 1995, pp 575-590.
2. Kirby R: Critical care: The overview. Vet Clin North Am Sm Anim Pract 19:1007-1019, 1989.
3. Schertel E, Muir W: Shock: Pathophysiology, monitoring, and therapy, in Kirk RW (ed): Current Veterinary Therapy X. Philadelphia, WB Saunders Co, 1989, pp 316-330.
4. Hankes GH: Therapy of shock: The corticosteroid question. Vet Clin North Am Sm Anim Pract 6:277-285, 1976.
5. Bistner SI, Ford RB: Shock, in Raffe M (ed): Kirk and Bistner's Handbook of Veterinary Procedures & Emergency Treatment, ed 6. Philadelphia, WB Saunders Co, 1995, pp 39-54.
6. Fagella AM: Introduction to critical care, in Morgan R (ed): Handbook of Small Animal Practice, ed 2. New York, Churchill Livingstone, 1992, pp 1353-1360.
7. Reichgott MJ, Melmon KL: Should corticosteroids be used in shock? Med Clin North Am 57:1211-1223, 1973.
8. Lundberg D: The pharmacological basis of treatment with high dose corticosteroids in circulatory shock. Acta Chir Scand 526:7-12, 1985.
9. Wilson RF: Science and shock: A clinical perspective. Ann Emerg Med 14:714-723, 1985.
10. Lefer AM, Verrier RL: Role of corticosteroids in the treatment of circulatory collapse states. Clin Pharmacol Ther 11:630-655, 1970.
11. Bellamy RF, Maningas PA, Wenger BA: Current shock models and clinical correlations. Ann Emerg Med 15: 1392-1395, 1986.
12. Weil MH, Whigham H: Corticosteroids for reversal of hemorrhagic shock in rats. Am J Physiol 209:815-818, 1965.
13. Lefer AM, Martin J: Mechanism of the protective effect of corticosteroids in hemorrhagic shock. Am J Physiol 216: 314-320, 1969.
14. Glenn TM, Lefer AM: Anti-toxic action of methylprednisolone in hemorrhagic shock. Eur J Pharmacol 13: 230-238, 1971.
15. Hakstian RW, Hampson LG, Gurd FN: Pharmacological agents in experimental hemorrhagic shock. Arch Surg 83:335-346, 1961.
16. Nagy S, Tarnoky K, Petri G: Effect of a water-soluble corticosteroid analogue in experimental hemorrhagic shock. J Surg Res 4:62-69, 1964.
17. Dillon R, Hankes GH, Nachreiner RF, Redding RW: Experimental hemorrhage in dogs: Effects of prednisolone sodium succinate. JAAHA 14:673-682, 1978.
18. Connors RH, Coran AG, Wesley JR, et al: Corticosteroid therapy in hemorrhagic and septic shock in puppies. J Pediatr Surg 15:790-796, 1980.
19. Sayers G, Solomon N: Work performance of a rat heart-lung preparation: Standardization and influence of corticosteroids. Endocrinology 66:719-730, 1960.
20. Tanz RD: Studies on the action of cortisone acetate on isolated cardiac tissue. J Pharmacol Exp Ther 128:168-175, 1960.
21. Jewitt DE, Skelton CL, Sonnenblick EH: Salutary effect of methyl prednisolone on the viability of heart muscle exposed to anoxia (Abstr). Circulation 45-46:121, 1972.
22. Lillehei RC, Longerbeam JK, Bloch JH, Manax WG: The nature of irreversible shock: Experimental and clinical observations. Ann Surg 160:682-710, 1964.
23. Dietzman RH, Lillehei RC: The treatment of cardiogenic shock. V. The use of corticosteroids in the treatment of cardiogenic shock. Am Heart J 75:274-277, 1968.
24. Dietzman RH, Bloch JH, Lillehei RC: The role of steroids as vasodilators in cardiogenic shock (Abstract). Am J Cardiol 21:96-97, 1968.
25. Chou CC, Rudko M, Haddy FJ: Effects of hydrocortisone on forelimb resistance responses to vasoactive agents in intact and adrenalectomized dogs (Abstract). Clin Res 16:433, 1968.
26. Altura BM, Altura BT: Peripheral vascular actions of glucocorticoids and their relationship to protection in circulatory shock. J Pharmacol Exp Ther 190:300-315, 1974.
27. Spinck WW, Vick JA: Evaluation of plasma, metaraminol and hydrocortisone in experimental endotoxin shock. Circ Res 9:184-188, 1961.
28. Thompson EB, Lippman ME: Mechanism of action of glucocorticoids. Metabolism 23:159-202, 1974.
29. 2 activity. Biochim Biophys Acta 1127:163-167, 1992.
30. Johnston SA, Fox SM: Mechanisms of action of anti-inflammatory medications used for the treatment of osteoarthritis. JAVMA 210(10):1486-1492, 1997.
31. 2 formation. N Engl J Med 319:689-698, 1988.
32. Moncada S, Palmer RM, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142, 1991.
33. Weissmann G: The effect of neutral steroids and bile acids on lysosomes in vitro. Biochem Pharmacol 14:525-535, 1965.
34. Bell ML, Herman AH, Smith EE, et al: Role of lysosomal instability in the development of refractory shock. Surgery 70:341-347, 1971.
35. de Duve C, Wattiaux R, Wibo M: Effects of fat-soluble compounds on lysosomes in vitro. Biochem Pharmacol 9: 97-116, 1962.
36. Weissmann G, Thomas L: The effects of endotoxin, endotoxin tolerance, and cortisone on the release of acid hydrolases from a granular fraction of rabbit liver. J Exp Med 116:433-450, 1962.
37. Tanaka K, Iizuka Y: Suppression of enzyme release from isolated rat liver lysosomes by non-steroidal anti-inflammatory drugs. Biochem Pharmacol 17:2023-2032, 1968.
38. Janoff A, Weissmann G, Zweifach BW, Thomas L: Studies on lysosomes in normal and tolerant animals subjected to lethal trauma and endotoxemia. J Exp Med 116:451-466, 1962.
39. Clermont HG, Williams JS, Adams JT: Steroid effect on the release of the lysosomal enzyme acid phosphatase in shock. Ann Surg 179:917-921, 1974.
40. Schumer W, Kukral JC: Metabolism of shock. Surgery 63:630-636, 1968.
41. Schumer W: Cellular metabolism in shock. Circ Shock 2:109-127, 1975.
42. Wass CT, Lanier WL: Glucose modulation of ischemic brain injury: Review and clinical recommendations. Mayo Clin Proc 71:801-812, 1996.
43. Wass CT, Scheuthauer BW, Bronk JT, et al: Insulin treatment of corticosteroid-associated hyperglycemia and its effect on outcome after forebrain ischemia in rats. Anesthesiology 84:644-651, 1996.
44. Munck A, Naray-Fejes-Toth A: Glucocorticoids and stress: Permissive and suppressive actions. Ann NY Acad Sci 746:115-130, 1994.
45. Bertini R, Bianchi M, Ghezzi P: Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J Exp Med 167:1708-1712, 1988.
46. Hammerschmidt DE, White JG, Craddock PR, Jacob HS: Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states. J Clin Invest 63:798-803, 1979.
47. Sambhi MP, Weil MH, Udhoji VN: Acute pharmacodynamic effects of glucocorticoids: Cardiac output and related hemodynamic changes in normal subjects and patients in shock. Circulation 31:523-530, 1965.
48. Ziegler EJ, Fisher CJ Jr, Sprung CL, et al: Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med 324:429-436, 1991.
49. Greenman RL, Schein RM, Martin MA, et al: A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA 266:1097-1102, 1991.
50. Sorjonen DC, Dillon AR, Powers RD, Spano JS: Effects of dexamethasone and surgical hypotension on the stomach of dogs: Clinical, endoscopic, and pathologic evaluations. Am J Vet Res 44:1233-1237, 1983.
51. Moreland KJ: Ulcer disease of the upper gastrointestinal tract in small animals: Pathophysiology, diagnosis, and management. Compend Contin Educ Pract Vet 10:1265-1279, 1988.
52. Meuleman J, Katz P: The immunologic effects, kinetics, and use of glucocorticosteroids. Med Clin North Am 69:805-816, 1985.
53. Baker RJ, Shoemaker WC: Changing concepts in treatment of hypovolemic shock. Med Clin North Am 51:83-96, 1967.